CRRAB-L

Product Introduction CRRAB-L

• Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger?Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid medications.
• Rabeprazole, a PPI that inhibits acid & Levosulpiride, an anti-psychotic & Prokinetic drug that increases the movement in GI tract. It is indicated in the treatment of gastroesophageal reflux disease (GERD) in Patients who do not respond to monotherapy with PPI?s. It is also indicated in Zollinger-Ellison syndrome, gastric and duodenal ulcers.

Indication of CRRAB-L

• Rabeprazole, a PPI that inhibits acid & Levosulpiride, an anti-psychotic & Prokinetic drug that increases the movement in GI tract.
• It is indicated in the treatment of gastroesophageal reflux disease (GERD) in Patients who do not respond to monotherapy with PPI?s.
• It is also indicated in Zollinger-Ellison syndrome, gastric and duodenal ulcers.

Side Effects

• Common side effects are Headache, nausea, vomiting, constipation, diarrhea, gas and sore throat.